カテゴリ： LP Information, 世界, 医療/バイオ

mRNAワクチン及び治療薬原料の世界市場2025-2031：感染症ワクチン、がんワクチン、その他

■ 英語タイトル：Global mRNA Vaccine and Therapeutics Raw Material Market Growth 2025-2031

調査会社LP Information社が発行したリサーチレポート（データ管理コード：LP22DC5028）■ 発行会社/調査会社：LP Information
■ 商品コード：LP22DC5028
■ 発行日：2025年2月
■ 調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
■ 産業分野：医薬品
■ ページ数：117
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥527,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥790,560見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,054,080見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※LP Information社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[mRNAワクチン及び治療薬原料の世界市場2025-2031：感染症ワクチン、がんワクチン、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

mRNAワクチン及び治療薬原料のグローバル市場規模は、2024年のxxx百万ドルから2031年までにxxx百万ドルに増加すると推定されており、2024年～2031年の年平均成長率（CAGR）はxx%を示しています。貿易戦争とロシア・ウクライナ戦争の不確実性を念頭に置いて、さまざまな最終用途部門に対する貿易戦争の直接的および間接的な影響を継続的に追跡・分析しています。これらのインサイトは、主要な市場要因としてレポートに含まれています。
mRNAワクチン及び治療薬原料のアジア太平洋市場は、2024年にxxx百万ドルの市場規模が見込まれ、2024年～2031年にかけて約xx%のCAGRで成長すると予想されています。mRNAワクチン及び治療薬原料の米国市場は、2024年にxxx百万ドルの規模があり、2024年～2031年にかけて約xx%のCAGRで成長すると予想されています。mRNAワクチン及び治療薬原料のヨーロッパ市場は、2024年にxxx百万ドルの規模が見込まれ、2024年～2031年にかけて約xx%のCAGRで成長すると予想されています。mRNAワクチン及び治療薬原料の中国市場は、2024年にxxx百万ドルの規模があり、2024年～2031年にかけて約xx%のCAGRで成長すると予想されています。

世界の主要なmRNAワクチン及び治療薬原料関連企業としては、Jena Bioscience、 Thermo Fisher Scientific Inc.、 SBS Genetech、 Lucigen、 Sigma Aldrich、 Moderna Therapeutics、 CureVac、 Translate Bio、 BioNTech、 Sangamo Therapeutics、 Argos Therapeutics、 In-Cell-Art、 Etherna、 Ethris、 Tiba Biotechnology、 Product Type Insightsなどをカバーしています。売上の面では世界最大の2社が2024年にほぼxx%の市場シェアを占めています。

*** レポート範囲 ***

この最新のレポートはすべての重要な側面をカバーしながらmRNAワクチン及び治療薬原料のグローバル市場に関する深いインサイトを提供します。これは、市場のマクロな概要から、市場規模、競争環境、開発動向、ニッチ市場、主要な市場ドライバーと課題、バリュー チェーン分析などのミクロの詳細にまで及びます。当レポートは読者が貿易戦争およびロシア・ウクライナ戦争中に世界中でmRNAワクチン及び治療薬原料市場シナリオがどのように変化したかを理解できるように定量的データと定性的データの両方を使用して、mRNAワクチン及び治療薬原料のグローバル市場の全体像を提供することを目的としています。

分析の対象となる基準年は2024年で、市場の予測は2024年～2031年までのものです。

*** 市場セグメンテーション ***

この調査ではmRNAワクチン及び治療薬原料市場を細分化し、種類別 (感染症ワクチン、がんワクチン、その他)、用途別 (病院・診療所、外来・手術センター、その他)、および地域別 (アジア太平洋、アメリカ州、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：感染症ワクチン、がんワクチン、その他

・用途別区分：病院・診療所、外来・手術センター、その他

・地域別区分
アメリカ州（アメリカ、カナダ、メキシコ、ブラジル）
APAC/アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

*** 各章の紹介 ***
第1章：mRNAワクチン及び治療薬原料の範囲、調査方法など
第2章：エグゼクティブサマリー、世界のmRNAワクチン及び治療薬原料市場規模 (販売量、売上) およびCAGR、地域別・種類別・用途別、2020年～2024年までの推移データ、および2031年までの市場予測
第3章：企業別mRNAワクチン及び治療薬原料の販売量、売上、平均価格、グローバル市場シェア、および業界ランキング
第4章：地域別および国別のmRNAワクチン及び治療薬原料の販売量と売上（米国、カナダ、ヨーロッパ、中国、日本、韓国、東南アジア、インド、ラテンアメリカ、中東・アフリカなど）
第5/6/7/8章：アメリカ州、アジア太平洋、ヨーロッパ、中東・アフリカの国別、種類別の販売セグメント
第9章：市場動向、市場予測、機会、将来の市場に影響を与える経済動向の分析
第10章：製造コスト構造分析
第11章：販売チャンネル、販売業者および顧客
第12章：地域別、国別、種類別、用途別の世界のmRNAワクチン及び治療薬原料市場規模予測
第13章：主要企業の包括的な企業プロファイル
第14章：調査の結果

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：mRNAワクチン及び治療薬原料の年間販売量2020-2031、地域別現状・将来分析
・mRNAワクチン及び治療薬原料の種類別セグメント：感染症ワクチン、がんワクチン、その他
・mRNAワクチン及び治療薬原料の種類別販売量：2020-2024年の販売量、売上、市場シェア、販売価格
・mRNAワクチン及び治療薬原料の用途別セグメント：病院・診療所、外来・手術センター、その他
・mRNAワクチン及び治療薬原料の用途別販売量：2020-2024年の販売量、売上、市場シェア、販売価格

企業別世界のmRNAワクチン及び治療薬原料市場
・企業別のグローバルmRNAワクチン及び治療薬原料市場データ：2022-2024年の年間販売量、市場シェア
・企業別のmRNAワクチン及び治療薬原料の年間売上：2022-2024年の売上、市場シェア
・企業別のmRNAワクチン及び治療薬原料販売価格
・主要企業のmRNAワクチン及び治療薬原料生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

mRNAワクチン及び治療薬原料の地域別レビュー
・地域別のmRNAワクチン及び治療薬原料市場規模2020-2024：年間販売量、売上
・主要国別のmRNAワクチン及び治療薬原料市場規模2020-2024：年間販売量、売上
・アメリカ州のmRNAワクチン及び治療薬原料販売の成長
・アジア太平洋のmRNAワクチン及び治療薬原料販売の成長
・ヨーロッパのmRNAワクチン及び治療薬原料販売の成長
・中東・アフリカのmRNAワクチン及び治療薬原料販売の成長

アメリカ州市場
・アメリカ州の国別のmRNAワクチン及び治療薬原料販売量、売上（2020-2024）
・アメリカ州のmRNAワクチン及び治療薬原料の種類別販売量
・アメリカ州のmRNAワクチン及び治療薬原料の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋（APAC）市場
・アジア太平洋の国別のmRNAワクチン及び治療薬原料販売量、売上（2020-2024）
・アジア太平洋のmRNAワクチン及び治療薬原料の種類別販売量
・アジア太平洋のmRNAワクチン及び治療薬原料の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のmRNAワクチン及び治療薬原料販売量、売上（2020-2024）
・ヨーロッパのmRNAワクチン及び治療薬原料の種類別販売量
・ヨーロッパのmRNAワクチン及び治療薬原料の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のmRNAワクチン及び治療薬原料販売量、売上（2020-2024）
・中東・アフリカのmRNAワクチン及び治療薬原料の種類別販売量
・中東・アフリカのmRNAワクチン及び治療薬原料の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・mRNAワクチン及び治療薬原料の製造コスト構造分析
・mRNAワクチン及び治療薬原料の製造プロセス分析
・mRNAワクチン及び治療薬原料の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・mRNAワクチン及び治療薬原料の主要なグローバル販売業者
・mRNAワクチン及び治療薬原料の主要なグローバル顧客

地域別のmRNAワクチン及び治療薬原料市場予測レビュー
・地域別のmRNAワクチン及び治療薬原料市場規模予測（2025-2031）
・アメリカ州の国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・mRNAワクチン及び治療薬原料の種類別市場規模予測
・mRNAワクチン及び治療薬原料の用途別市場規模予測

主要企業分析
Jena Bioscience、 Thermo Fisher Scientific Inc.、 SBS Genetech、 Lucigen、 Sigma Aldrich、 Moderna Therapeutics、 CureVac、 Translate Bio、 BioNTech、 Sangamo Therapeutics、 Argos Therapeutics、 In-Cell-Art、 Etherna、 Ethris、 Tiba Biotechnology、 Product Type Insights
・企業情報
・mRNAワクチン及び治療薬原料製品
・mRNAワクチン及び治療薬原料販売量、売上、価格、粗利益（2022-2024）
・主要ビジネス概要
・最新動向

調査の結果

The global market for mRNA Vaccine and Therapeutics Raw Material is estimated to increase from US$ million in 2024 to reach US$ million by 2031, exhibiting a CAGR of % during 2025-2031. Keeping in mind the uncertainties of Trade War and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of trade war on different end use sectors. These insights are included in the report as a major market contributor.
The APAC mRNA Vaccine and Therapeutics Raw Material market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
The United States mRNA Vaccine and Therapeutics Raw Material market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
The Europe mRNA Vaccine and Therapeutics Raw Material market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
The China mRNA Vaccine and Therapeutics Raw Material market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
Global key mRNA Vaccine and Therapeutics Raw Material players cover Jena Bioscience, Thermo Fisher Scientific Inc., SBS Genetech, Lucigen and Sigma Aldrich, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2024.

[Report Coverage]
This latest report provides a deep insight into the global mRNA Vaccine and Therapeutics Raw Material market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global mRNA Vaccine and Therapeutics Raw Material market, with both quantitative and qualitative data, to help readers understand how the mRNA Vaccine and Therapeutics Raw Material market scenario changed across the globe during trade war and Russia-Ukraine War.
The base year considered for analyses is 2024, while the market estimates and forecasts are given from 2025 to 2031. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

[Market Segmentation]
The study segments the mRNA Vaccine and Therapeutics Raw Material market and forecasts the market size by Type (Infectious Disease Vaccines, Cancer Vaccine and Others), by Application (Hospitals and Clinics, Outpatient and Surgery Centers and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Infectious Disease Vaccines
Cancer Vaccine
Others
Segmentation by application
Hospitals and Clinics
Outpatient and Surgery Centers
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Jena Bioscience
Thermo Fisher Scientific Inc.
SBS Genetech
Lucigen
Sigma Aldrich
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
Etherna
Ethris
Tiba Biotechnology
Product Type Insights

[Chapter Introduction]
Chapter 1: Scope of mRNA Vaccine and Therapeutics Raw Material, Research Methodology, etc.
Chapter 2: Executive Summary, global mRNA Vaccine and Therapeutics Raw Material market size (sales and revenue) and CAGR, mRNA Vaccine and Therapeutics Raw Material market size by region, by type, by application, historical data from 2020 to 2025, and forecast to 2031.
Chapter 3: mRNA Vaccine and Therapeutics Raw Material sales, revenue, average price, global market share, and industry ranking by company, 2020-2024
Chapter 4: Global mRNA Vaccine and Therapeutics Raw Material sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global mRNA Vaccine and Therapeutics Raw Material market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Jena Bioscience, Thermo Fisher Scientific Inc., SBS Genetech, Lucigen, Sigma Aldrich, Moderna Therapeutics, CureVac, Translate Bio and BioNTech, etc.
Chapter 14: Research Findings and Conclusion

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global mRNA Vaccine and Therapeutics Raw Material Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for mRNA Vaccine and Therapeutics Raw Material by Geographic Region, 2020, 2025 & 2031
2.1.3 World Current & Future Analysis for mRNA Vaccine and Therapeutics Raw Material by Country/Region, 2020, 2025 & 2031
2.2 mRNA Vaccine and Therapeutics Raw Material Segment by Type
2.2.1 Infectious Disease Vaccines
2.2.2 Cancer Vaccine
2.2.3 Others
2.3 mRNA Vaccine and Therapeutics Raw Material Sales by Type
2.3.1 Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Type (2020-2024)
2.3.2 Global mRNA Vaccine and Therapeutics Raw Material Revenue and Market Share by Type (2020-2024)
2.3.3 Global mRNA Vaccine and Therapeutics Raw Material Sale Price by Type (2020-2024)
2.4 mRNA Vaccine and Therapeutics Raw Material Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Outpatient and Surgery Centers
2.4.3 Others
2.5 mRNA Vaccine and Therapeutics Raw Material Sales by Application
2.5.1 Global mRNA Vaccine and Therapeutics Raw Material Sale Market Share by Application (2020-2024)
2.5.2 Global mRNA Vaccine and Therapeutics Raw Material Revenue and Market Share by Application (2020-2024)
2.5.3 Global mRNA Vaccine and Therapeutics Raw Material Sale Price by Application (2020-2024)
3 Global mRNA Vaccine and Therapeutics Raw Material by Company
3.1 Global mRNA Vaccine and Therapeutics Raw Material Breakdown Data by Company
3.1.1 Global mRNA Vaccine and Therapeutics Raw Material Annual Sales by Company (2022-2024)
3.1.2 Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Company (2022-2024)
3.2 Global mRNA Vaccine and Therapeutics Raw Material Annual Revenue by Company (2022-2024)
3.2.1 Global mRNA Vaccine and Therapeutics Raw Material Revenue by Company (2022-2024)
3.2.2 Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Company (2022-2024)
3.3 Global mRNA Vaccine and Therapeutics Raw Material Sale Price by Company
3.4 Key Manufacturers mRNA Vaccine and Therapeutics Raw Material Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA Vaccine and Therapeutics Raw Material Product Location Distribution
3.4.2 Players mRNA Vaccine and Therapeutics Raw Material Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for mRNA Vaccine and Therapeutics Raw Material by Geographic Region
4.1 World Historic mRNA Vaccine and Therapeutics Raw Material Market Size by Geographic Region (2020-2024)
4.1.1 Global mRNA Vaccine and Therapeutics Raw Material Annual Sales by Geographic Region (2020-2024)
4.1.2 Global mRNA Vaccine and Therapeutics Raw Material Annual Revenue by Geographic Region
4.2 World Historic mRNA Vaccine and Therapeutics Raw Material Market Size by Country/Region (2020-2024)
4.2.1 Global mRNA Vaccine and Therapeutics Raw Material Annual Sales by Country/Region (2020-2024)
4.2.2 Global mRNA Vaccine and Therapeutics Raw Material Annual Revenue by Country/Region
4.3 Americas mRNA Vaccine and Therapeutics Raw Material Sales Growth
4.4 APAC mRNA Vaccine and Therapeutics Raw Material Sales Growth
4.5 Europe mRNA Vaccine and Therapeutics Raw Material Sales Growth
4.6 Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Sales Growth
5 Americas
5.1 Americas mRNA Vaccine and Therapeutics Raw Material Sales by Country
5.1.1 Americas mRNA Vaccine and Therapeutics Raw Material Sales by Country (2020-2024)
5.1.2 Americas mRNA Vaccine and Therapeutics Raw Material Revenue by Country (2020-2024)
5.2 Americas mRNA Vaccine and Therapeutics Raw Material Sales by Type
5.3 Americas mRNA Vaccine and Therapeutics Raw Material Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Vaccine and Therapeutics Raw Material Sales by Region
6.1.1 APAC mRNA Vaccine and Therapeutics Raw Material Sales by Region (2020-2024)
6.1.2 APAC mRNA Vaccine and Therapeutics Raw Material Revenue by Region (2020-2024)
6.2 APAC mRNA Vaccine and Therapeutics Raw Material Sales by Type
6.3 APAC mRNA Vaccine and Therapeutics Raw Material Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe mRNA Vaccine and Therapeutics Raw Material by Country
7.1.1 Europe mRNA Vaccine and Therapeutics Raw Material Sales by Country (2020-2024)
7.1.2 Europe mRNA Vaccine and Therapeutics Raw Material Revenue by Country (2020-2024)
7.2 Europe mRNA Vaccine and Therapeutics Raw Material Sales by Type
7.3 Europe mRNA Vaccine and Therapeutics Raw Material Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa mRNA Vaccine and Therapeutics Raw Material by Country
8.1.1 Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Sales by Country (2020-2024)
8.1.2 Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Revenue by Country (2020-2024)
8.2 Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Sales by Type
8.3 Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA Vaccine and Therapeutics Raw Material
10.3 Manufacturing Process Analysis of mRNA Vaccine and Therapeutics Raw Material
10.4 Industry Chain Structure of mRNA Vaccine and Therapeutics Raw Material
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA Vaccine and Therapeutics Raw Material Distributors
11.3 mRNA Vaccine and Therapeutics Raw Material Customer
12 World Forecast Review for mRNA Vaccine and Therapeutics Raw Material by Geographic Region
12.1 Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Region
12.1.1 Global mRNA Vaccine and Therapeutics Raw Material Forecast by Region (2025-2031)
12.1.2 Global mRNA Vaccine and Therapeutics Raw Material Annual Revenue Forecast by Region (2025-2031)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global mRNA Vaccine and Therapeutics Raw Material Forecast by Type
12.7 Global mRNA Vaccine and Therapeutics Raw Material Forecast by Application
13 Key Players Analysis
13.1 Jena Bioscience
13.1.1 Jena Bioscience Company Information
13.1.2 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product Offered
13.1.3 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.1.4 Jena Bioscience Main Business Overview
13.1.5 Jena Bioscience Latest Developments
13.2 Thermo Fisher Scientific Inc.
13.2.1 Thermo Fisher Scientific Inc. Company Information
13.2.2 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product Offered
13.2.3 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.2.4 Thermo Fisher Scientific Inc. Main Business Overview
13.2.5 Thermo Fisher Scientific Inc. Latest Developments
13.3 SBS Genetech
13.3.1 SBS Genetech Company Information
13.3.2 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product Offered
13.3.3 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.3.4 SBS Genetech Main Business Overview
13.3.5 SBS Genetech Latest Developments
13.4 Lucigen
13.4.1 Lucigen Company Information
13.4.2 Lucigen mRNA Vaccine and Therapeutics Raw Material Product Offered
13.4.3 Lucigen mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.4.4 Lucigen Main Business Overview
13.4.5 Lucigen Latest Developments
13.5 Sigma Aldrich
13.5.1 Sigma Aldrich Company Information
13.5.2 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product Offered
13.5.3 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.5.4 Sigma Aldrich Main Business Overview
13.5.5 Sigma Aldrich Latest Developments
13.6 Moderna Therapeutics
13.6.1 Moderna Therapeutics Company Information
13.6.2 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Offered
13.6.3 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.6.4 Moderna Therapeutics Main Business Overview
13.6.5 Moderna Therapeutics Latest Developments
13.7 CureVac
13.7.1 CureVac Company Information
13.7.2 CureVac mRNA Vaccine and Therapeutics Raw Material Product Offered
13.7.3 CureVac mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.7.4 CureVac Main Business Overview
13.7.5 CureVac Latest Developments
13.8 Translate Bio
13.8.1 Translate Bio Company Information
13.8.2 Translate Bio mRNA Vaccine and Therapeutics Raw Material Product Offered
13.8.3 Translate Bio mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.8.4 Translate Bio Main Business Overview
13.8.5 Translate Bio Latest Developments
13.9 BioNTech
13.9.1 BioNTech Company Information
13.9.2 BioNTech mRNA Vaccine and Therapeutics Raw Material Product Offered
13.9.3 BioNTech mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.9.4 BioNTech Main Business Overview
13.9.5 BioNTech Latest Developments
13.10 Sangamo Therapeutics
13.10.1 Sangamo Therapeutics Company Information
13.10.2 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Offered
13.10.3 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.10.4 Sangamo Therapeutics Main Business Overview
13.10.5 Sangamo Therapeutics Latest Developments
13.11 Argos Therapeutics
13.11.1 Argos Therapeutics Company Information
13.11.2 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Offered
13.11.3 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.11.4 Argos Therapeutics Main Business Overview
13.11.5 Argos Therapeutics Latest Developments
13.12 In-Cell-Art
13.12.1 In-Cell-Art Company Information
13.12.2 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product Offered
13.12.3 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.12.4 In-Cell-Art Main Business Overview
13.12.5 In-Cell-Art Latest Developments
13.13 Etherna
13.13.1 Etherna Company Information
13.13.2 Etherna mRNA Vaccine and Therapeutics Raw Material Product Offered
13.13.3 Etherna mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.13.4 Etherna Main Business Overview
13.13.5 Etherna Latest Developments
13.14 Ethris
13.14.1 Ethris Company Information
13.14.2 Ethris mRNA Vaccine and Therapeutics Raw Material Product Offered
13.14.3 Ethris mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.14.4 Ethris Main Business Overview
13.14.5 Ethris Latest Developments
13.15 Tiba Biotechnology
13.15.1 Tiba Biotechnology Company Information
13.15.2 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product Offered
13.15.3 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.15.4 Tiba Biotechnology Main Business Overview
13.15.5 Tiba Biotechnology Latest Developments
13.16 Product Type Insights
13.16.1 Product Type Insights Company Information
13.16.2 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product Offered
13.16.3 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Sales, Revenue, Price and Gross Margin (2022-2024)
13.16.4 Product Type Insights Main Business Overview
13.16.5 Product Type Insights Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. mRNA Vaccine and Therapeutics Raw Material Annual Sales CAGR by Geographic Region (2020, 2025 & 2031) & ($ millions)
Table 2. mRNA Vaccine and Therapeutics Raw Material Annual Sales CAGR by Country/Region (2020, 2025 & 2031) & ($ millions)
Table 3. Major Players of Infectious Disease Vaccines
Table 4. Major Players of Cancer Vaccine
Table 5. Major Players of Others
Table 6. Global mRNA Vaccine and Therapeutics Raw Material Sales by Type (2020-2024) & (K Units)
Table 7. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Type (2020-2024)
Table 8. Global mRNA Vaccine and Therapeutics Raw Material Revenue by Type (2020-2024) & ($ million)
Table 9. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Type (2020-2024)
Table 10. Global mRNA Vaccine and Therapeutics Raw Material Sale Price by Type (2020-2024) & (US$/Unit)
Table 11. Global mRNA Vaccine and Therapeutics Raw Material Sales by Application (2020-2024) & (K Units)
Table 12. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Application (2020-2024)
Table 13. Global mRNA Vaccine and Therapeutics Raw Material Revenue by Application (2020-2024)
Table 14. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Application (2020-2024)
Table 15. Global mRNA Vaccine and Therapeutics Raw Material Sale Price by Application (2020-2024) & (US$/Unit)
Table 16. Global mRNA Vaccine and Therapeutics Raw Material Sales by Company (2022-2024) & (K Units)
Table 17. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Company (2022-2024)
Table 18. Global mRNA Vaccine and Therapeutics Raw Material Revenue by Company (2022-2024) ($ Millions)
Table 19. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Company (2022-2024)
Table 20. Global mRNA Vaccine and Therapeutics Raw Material Sale Price by Company (2022-2024) & (US$/Unit)
Table 21. Key Manufacturers mRNA Vaccine and Therapeutics Raw Material Producing Area Distribution and Sales Area
Table 22. Players mRNA Vaccine and Therapeutics Raw Material Products Offered
Table 23. mRNA Vaccine and Therapeutics Raw Material Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global mRNA Vaccine and Therapeutics Raw Material Sales by Geographic Region (2020-2024) & (K Units)
Table 27. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share Geographic Region (2020-2024)
Table 28. Global mRNA Vaccine and Therapeutics Raw Material Revenue by Geographic Region (2020-2024) & ($ millions)
Table 29. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Geographic Region (2020-2024)
Table 30. Global mRNA Vaccine and Therapeutics Raw Material Sales by Country/Region (2020-2024) & (K Units)
Table 31. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country/Region (2020-2024)
Table 32. Global mRNA Vaccine and Therapeutics Raw Material Revenue by Country/Region (2020-2024) & ($ millions)
Table 33. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Country/Region (2020-2024)
Table 34. Americas mRNA Vaccine and Therapeutics Raw Material Sales by Country (2020-2024) & (K Units)
Table 35. Americas mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country (2020-2024)
Table 36. Americas mRNA Vaccine and Therapeutics Raw Material Revenue by Country (2020-2024) & ($ Millions)
Table 37. Americas mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Country (2020-2024)
Table 38. Americas mRNA Vaccine and Therapeutics Raw Material Sales by Type (2020-2024) & (K Units)
Table 39. Americas mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Type (2020-2024)
Table 40. Americas mRNA Vaccine and Therapeutics Raw Material Sales by Application (2020-2024) & (K Units)
Table 41. Americas mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Application (2020-2024)
Table 42. APAC mRNA Vaccine and Therapeutics Raw Material Sales by Region (2020-2024) & (K Units)
Table 43. APAC mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region (2020-2024)
Table 44. APAC mRNA Vaccine and Therapeutics Raw Material Revenue by Region (2020-2024) & ($ Millions)
Table 45. APAC mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Region (2020-2024)
Table 46. APAC mRNA Vaccine and Therapeutics Raw Material Sales by Type (2020-2024) & (K Units)
Table 47. APAC mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Type (2020-2024)
Table 48. APAC mRNA Vaccine and Therapeutics Raw Material Sales by Application (2020-2024) & (K Units)
Table 49. APAC mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Application (2020-2024)
Table 50. Europe mRNA Vaccine and Therapeutics Raw Material Sales by Country (2020-2024) & (K Units)
Table 51. Europe mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country (2020-2024)
Table 52. Europe mRNA Vaccine and Therapeutics Raw Material Revenue by Country (2020-2024) & ($ Millions)
Table 53. Europe mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Country (2020-2024)
Table 54. Europe mRNA Vaccine and Therapeutics Raw Material Sales by Type (2020-2024) & (K Units)
Table 55. Europe mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Type (2020-2024)
Table 56. Europe mRNA Vaccine and Therapeutics Raw Material Sales by Application (2020-2024) & (K Units)
Table 57. Europe mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Application (2020-2024)
Table 58. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Sales by Country (2020-2024) & (K Units)
Table 59. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country (2020-2024)
Table 60. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Revenue by Country (2020-2024) & ($ Millions)
Table 61. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Country (2020-2024)
Table 62. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Sales by Type (2020-2024) & (K Units)
Table 63. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Type (2020-2024)
Table 64. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Sales by Application (2020-2024) & (K Units)
Table 65. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Application (2020-2024)
Table 66. Key Market Drivers & Growth Opportunities of mRNA Vaccine and Therapeutics Raw Material
Table 67. Key Market Challenges & Risks of mRNA Vaccine and Therapeutics Raw Material
Table 68. Key Industry Trends of mRNA Vaccine and Therapeutics Raw Material
Table 69. mRNA Vaccine and Therapeutics Raw Material Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. mRNA Vaccine and Therapeutics Raw Material Distributors List
Table 72. mRNA Vaccine and Therapeutics Raw Material Customer List
Table 73. Global mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Region (2025-2031) & (K Units)
Table 74. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Forecast by Region
Table 75. Global mRNA Vaccine and Therapeutics Raw Material Revenue Forecast by Region (2025-2031) & ($ millions)
Table 76. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share Forecast by Region (2025-2031)
Table 77. Americas mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Country (2025-2031) & (K Units)
Table 78. Americas mRNA Vaccine and Therapeutics Raw Material Revenue Forecast by Country (2025-2031) & ($ millions)
Table 79. APAC mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Region (2025-2031) & (K Units)
Table 80. APAC mRNA Vaccine and Therapeutics Raw Material Revenue Forecast by Region (2025-2031) & ($ millions)
Table 81. Europe mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Country (2025-2031) & (K Units)
Table 82. Europe mRNA Vaccine and Therapeutics Raw Material Revenue Forecast by Country (2025-2031) & ($ millions)
Table 83. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Country (2025-2031) & (K Units)
Table 84. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Revenue Forecast by Country (2025-2031) & ($ millions)
Table 85. Global mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Type (2025-2031) & (K Units)
Table 86. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share Forecast by Type (2025-2031)
Table 87. Global mRNA Vaccine and Therapeutics Raw Material Revenue Forecast by Type (2025-2031) & ($ Millions)
Table 88. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share Forecast by Type (2025-2031)
Table 89. Global mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Application (2025-2031) & (K Units)
Table 90. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share Forecast by Application (2025-2031)
Table 91. Global mRNA Vaccine and Therapeutics Raw Material Revenue Forecast by Application (2025-2031) & ($ Millions)
Table 92. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share Forecast by Application (2025-2031)
Table 93. Jena Bioscience Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 94. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 95. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 96. Jena Bioscience Main Business
Table 97. Jena Bioscience Latest Developments
Table 98. Thermo Fisher Scientific Inc. Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 99. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 100. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 101. Thermo Fisher Scientific Inc. Main Business
Table 102. Thermo Fisher Scientific Inc. Latest Developments
Table 103. SBS Genetech Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 104. SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 105. SBS Genetech mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 106. SBS Genetech Main Business
Table 107. SBS Genetech Latest Developments
Table 108. Lucigen Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 109. Lucigen mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 110. Lucigen mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 111. Lucigen Main Business
Table 112. Lucigen Latest Developments
Table 113. Sigma Aldrich Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 114. Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 115. Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 116. Sigma Aldrich Main Business
Table 117. Sigma Aldrich Latest Developments
Table 118. Moderna Therapeutics Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 119. Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 120. Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 121. Moderna Therapeutics Main Business
Table 122. Moderna Therapeutics Latest Developments
Table 123. CureVac Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 124. CureVac mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 125. CureVac mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 126. CureVac Main Business
Table 127. CureVac Latest Developments
Table 128. Translate Bio Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 129. Translate Bio mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 130. Translate Bio mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 131. Translate Bio Main Business
Table 132. Translate Bio Latest Developments
Table 133. BioNTech Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 134. BioNTech mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 135. BioNTech mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 136. BioNTech Main Business
Table 137. BioNTech Latest Developments
Table 138. Sangamo Therapeutics Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 139. Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 140. Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 141. Sangamo Therapeutics Main Business
Table 142. Sangamo Therapeutics Latest Developments
Table 143. Argos Therapeutics Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 144. Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 145. Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 146. Argos Therapeutics Main Business
Table 147. Argos Therapeutics Latest Developments
Table 148. In-Cell-Art Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 149. In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 150. In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 151. In-Cell-Art Main Business
Table 152. In-Cell-Art Latest Developments
Table 153. Etherna Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 154. Etherna mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 155. Etherna mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 156. Etherna Main Business
Table 157. Etherna Latest Developments
Table 158. Ethris Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 159. Ethris mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 160. Ethris mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 161. Ethris Main Business
Table 162. Ethris Latest Developments
Table 163. Tiba Biotechnology Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 164. Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 165. Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 166. Tiba Biotechnology Main Business
Table 167. Tiba Biotechnology Latest Developments
Table 168. Product Type Insights Basic Information, mRNA Vaccine and Therapeutics Raw Material Manufacturing Base, Sales Area and Its Competitors
Table 169. Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product Offered
Table 170. Product Type Insights mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 171. Product Type Insights Main Business
Table 172. Product Type Insights Latest Developments
List of Figures
Figure 1. Picture of mRNA Vaccine and Therapeutics Raw Material
Figure 2. mRNA Vaccine and Therapeutics Raw Material Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA Vaccine and Therapeutics Raw Material Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global mRNA Vaccine and Therapeutics Raw Material Revenue Growth Rate 2020-2031 ($ Millions)
Figure 8. mRNA Vaccine and Therapeutics Raw Material Sales by Region (2024 & 2031) & ($ millions)
Figure 9. Product Picture of Infectious Disease Vaccines
Figure 10. Product Picture of Cancer Vaccine
Figure 11. Product Picture of Others
Figure 12. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Type in 2024
Figure 13. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Type (2020-2024)
Figure 14. mRNA Vaccine and Therapeutics Raw Material Consumed in Hospitals and Clinics
Figure 15. Global mRNA Vaccine and Therapeutics Raw Material Market: Hospitals and Clinics (2020-2024) & (K Units)
Figure 16. mRNA Vaccine and Therapeutics Raw Material Consumed in Outpatient and Surgery Centers
Figure 17. Global mRNA Vaccine and Therapeutics Raw Material Market: Outpatient and Surgery Centers (2020-2024) & (K Units)
Figure 18. mRNA Vaccine and Therapeutics Raw Material Consumed in Others
Figure 19. Global mRNA Vaccine and Therapeutics Raw Material Market: Others (2020-2024) & (K Units)
Figure 20. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Application (2020-2024)
Figure 21. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Application in 2024
Figure 22. mRNA Vaccine and Therapeutics Raw Material Revenue Market by Company in 2024 ($ Million)
Figure 23. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Company in 2024
Figure 24. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Geographic Region (2020-2024)
Figure 25. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Geographic Region in 2024
Figure 26. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region (2020-2024)
Figure 27. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Country/Region in 2024
Figure 28. Americas mRNA Vaccine and Therapeutics Raw Material Sales 2020-2024 (K Units)
Figure 29. Americas mRNA Vaccine and Therapeutics Raw Material Revenue 2020-2024 ($ Millions)
Figure 30. APAC mRNA Vaccine and Therapeutics Raw Material Sales 2020-2024 (K Units)
Figure 31. APAC mRNA Vaccine and Therapeutics Raw Material Revenue 2020-2024 ($ Millions)
Figure 32. Europe mRNA Vaccine and Therapeutics Raw Material Sales 2020-2024 (K Units)
Figure 33. Europe mRNA Vaccine and Therapeutics Raw Material Revenue 2020-2024 ($ Millions)
Figure 34. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Sales 2020-2024 (K Units)
Figure 35. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Revenue 2020-2024 ($ Millions)
Figure 36. Americas mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country in 2024
Figure 37. Americas mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Country in 2024
Figure 38. United States mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 39. Canada mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 40. Mexico mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 41. Brazil mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 42. APAC mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region in 2024
Figure 43. APAC mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Regions in 2024
Figure 44. China mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 45. Japan mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 46. South Korea mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 47. Southeast Asia mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 48. India mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 49. Australia mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 50. Europe mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country in 2024
Figure 51. Europe mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Country in 2024
Figure 52. Germany mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 53. France mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 54. UK mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 55. Italy mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 56. Russia mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 57. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country in 2024
Figure 58. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Country in 2024
Figure 59. Egypt mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 60. South Africa mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 61. Israel mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 62. Turkey mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 63. GCC Country mRNA Vaccine and Therapeutics Raw Material Revenue Growth 2020-2024 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of mRNA Vaccine and Therapeutics Raw Material in 2024
Figure 65. Manufacturing Process Analysis of mRNA Vaccine and Therapeutics Raw Material
Figure 66. Industry Chain Structure of mRNA Vaccine and Therapeutics Raw Material
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles

※参考情報

mRNAワクチン及び治療薬原料は、近年の医療技術の発展において非常に重要な役割を果たしています。これらは、特に新型コロナウイルス感染症（COVID-19）に対抗するために開発されたことが広く知られていますが、mRNA技術は他の疾患の治療や予防にも応用される可能性があります。以下に、mRNAワクチン及び治療薬原料の概念を詳しく説明します。

mRNAワクチンの定義は、メッセンジャーRNA（mRNA）を使用して体内で特定の抗原を生成させ、免疫応答を誘導する医薬品です。mRNA自体は、DNAからの遺伝情報を細胞に伝達し、タンパク質合成を促す役割を果たす分子です。mRNAワクチンでは、感染症を引き起こす病原体の一部をコードするmRNAが体内に導入されます。その結果、細胞はこのmRNAを読み取り、病原体の抗原を合成し、免疫系がその抗原に反応するように促します。この免疫応答により、実際の病原体が侵入した際に迅速かつ効果的に対処できるようになります。

mRNAワクチンの特徴として、まず迅速な開発能力が挙げられます。従来のワクチンは、病原体を弱毒化または不活化して製造する必要がありますが、mRNAワクチンはmRNAの合成が可能であれば短期間で製造できます。これにより、新しいウイルスの出現に対しても迅速に対応できることが期待されています。また、冷凍保存が必要な従来のワクチンと異なり、mRNAワクチンは比較的高い温度で保管が可能であるため、物流の面でも利点があります。

mRNAワクチンには、いくつかの種類があります。代表的なものとして、ファイザー社のComirnaty（BNT162b2）およびモデルナ社のSpikevax（mRNA-1273）があります。これらは、COVID-19に対するワクチンとして緊急使用が承認されました。どちらのワクチンも、ウイルスのスパイクタンパク質をターゲットにしており、このタンパク質の生成を通じて免疫系を刺激します。

mRNA技術は、ワクチンだけでなく治療薬の開発にも応用が期待されています。特にがん治療において、mRNAを使用してがん特異的な抗原をコードさせ、免疫系を活性化することにより、腫瘍に対する応答を強化することが可能です。このアプローチは、個別化医療の一環として注目されており、患者ごとのがん細胞の特徴に応じた治療が実現できる可能性があります。

mRNAワクチン及び治療薬の原料には、mRNA分子を効果的に細胞内に運ぶための脂質ナノ粒子（LNP）が含まれています。LNPは、mRNAを保護し、体内でのデリバリーを補助する役割を果たします。また、LNPは生体適合性が高く、細胞膜を通過する能力があるため、効率的にmRNAを細胞内に取り込むことができます。さらに、mRNAの設計自体も重要です。特に、mRNAの修飾や配列の最適化が行われることで、免疫応答の強化や持続性を高めることができます。

関連技術としては、合成生物学やナノテクノロジーが挙げられます。合成生物学は、遺伝子や生物学的機能を設計・改変することにより新しい生物学的システムを構築する技術であり、mRNAワクチンの開発においては効率的なmRNA合成法を見出すために用いられています。また、ナノテクノロジーは、mRNAを効果的に細胞に届けるための材料や構造を設計する上で重要な役割を果たしています。

mRNAワクチン及び治療薬の原料の関心は、現在も高まっており、将来的にはさらに多くの感染症や病状に対する治療の可能性が探られています。例えば、インフルエンザやHIV、さらには自己免疫疾患や遺伝子治療に対するmRNAの適用が研究されています。これにより、mRNA技術の進展は、医療分野に革命をもたらすと期待されています。

一方で、mRNA技術の普及に伴う課題も存在します。倫理的な観点や長期的な安全性の評価、製造プロセスの標準化など、技術の発展に伴ってクリアすべき問題も多くあります。また、ワクチンに関する誤情報の拡散や接種への抵抗など、公共の健康に対しても影響を及ぼしかねません。

mRNAワクチン及び治療薬原料は、今後の医療において重要な役割を果たすことが予想されています。新たな病原体の出現や既存の疾患に対する新しい治療法の開発により、より多くの命を救う助けとなるでしょう。そのためには、研究や技術開発と並行して、一般の理解を深め、信頼を得ることも重要です。mRNA技術は、未来の医療のパラダイムシフトをもたらす可能性を秘めており、その進展に期待が寄せられています。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • がん治療用生物製剤のグローバル市場（2023年-2030年）：モノクローナル抗体、サイトカインベース免疫療法、がんワクチン、CAR-T細胞療法、免疫チェックポイント阻害剤
  • がん免疫療法のグローバル市場（2024～2030）：モノクローナル抗体、免疫調節薬、がん溶解性ウイルス療法＆がんワクチン
  • がん免疫療法の世界市場（2024-2032）：モノクローナル抗体、がんワクチン、チェックポイント阻害剤、免疫調節剤、その他
  • 免疫療法治療薬の世界市場（2022年～2032年）：抗体医薬品、阻害医薬品、インターフェロン・インターロイキン、がんワクチン、その他
  • 吸入式新型コロナウイルス感染症ワクチンの世界市場2025-2031：18～30歳、30歳以上
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(LP22DC5028 )"mRNAワクチン及び治療薬原料の世界市場2025-2031：感染症ワクチン、がんワクチン、その他" (英文：Global mRNA Vaccine and Therapeutics Raw Material Market Growth 2025-2031)はLP Information社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。